AVR 1.00% $9.90 anteris technologies ltd

07.06.18 For personal use only ASX ANNOUNCEMENT ASX Market...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 442 Posts.
    lightbulb Created with Sketch. 7
    07.06.18

    For personal use only

    ASX ANNOUNCEMENT
    ASX Market Announcements
    Australian Securities Exchange Limited
    10th Floor, 20 Bond Street
    SYDNEY NSW 2000
    Admedus Limited (ASX:AHZ)
    ADMEDUS ANNOUNCES CONCLUSION OF RELATIONSHIP WITH GO MEDICAL
    Admedus Limited (ASX:AHZ) (the Company) today announces the conclusion of its
    relationship with Go Medical Industries Pty Ltd (Go Medical), a manufacturer of medical
    devices and accessories for the Infusion business.
    This change in our supplier arrangement is expected to have a 5.7% impact on top-line
    revenue for the financial year. It is important to note that this change relates only to the
    supply of smaller intravenous consumable medical products, and has no impact on
    Admedus’ distribution of infusion pumps to major hospitals.
    Under the leadership of its new Business Unit Head, Mr Glenn Gilchrist, the Company has
    been refreshing its long-term strategic plan for the Infusion business, which includes
    assessing its capabilities, organisational footprint, and product portfolio.
    The review identified certain products and pricing within the portfolio which needed to be
    more competitive. The Company engaged Go Medical on these topics, seeking a mutually
    beneficial outcome, but unfortunately were unable to reach agreement.
    Admedus is committed to working closely with existing customers and Go Medical as it
    transitions the business, and confirms it has adequate supply to meet demand during the 45day completion period.
    Admedus CEO Wayne Paterson commented on today’s announcement:
    “The Company believes that this outcome is in the best interest of all stakeholders in the
    short, medium, and long-term. While this may have a short-term impact on the timing of
    breakeven earnings, the Company still aims to be profitable for 2019. We have a great team
    in place who consistently deliver above-target sales revenue and offer premium service to
    our valued customers.”
    ENDS

    Admedus Limited
    ABN 35 088 221 078
    Registered Office
    Level 9
    301 Coronation Drive
    Milton QLD 4064

    Customer Service
    T 1300 550 310
    F 1300 880 398
    International
    T: +61 8 9266 0100
    F: +61 8 9266 0199

    E: [email protected]
    W: www.admedus.com

    Brisbane • Minneapolis
    Zurich • Singapore

    For personal use only

    About Admedus Limited

    Admedus (ASX:AHZ) is a medical technologies company delivering clinically superior
    solutions that help healthcare professionals create life-changing outcomes for patients. Our
    focus is on investing in and developing next generation technologies with world class
    partners, acquiring strategic assets to grow product and service offerings and expanding
    revenues from our existing medical sales and distribution business. The company has
    assets from research & development through clinical development as well as sales,
    marketing and distribution.
    Website:

    www.admedus.com

    Facebook:

    www.facebook.com/Admedus

    Twitter:

    @Admedus

    For more information, please contact:

    Admedus Limited
    Barbara Ferres
    +61 7 3152 3216
    [email protected]

    Admedus Limited
    ABN 35 088 221 078
    Registered Office
    Level 9
    301 Coronation Drive
    Milton QLD 4064

    Customer Service
    T 1300 550 310
    F 1300 880 398
    International
    T: +61 8 9266 0100
    F: +61 8 9266 0199

    E: [email protected]
    W: www.admedus.com

    Brisbane • Minneapolis
    Zurich • Singapore
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$9.90
Change
-0.100(1.00%)
Mkt cap ! $208.2M
Open High Low Value Volume
$10.00 $10.00 $9.65 $45.68K 4.654K

Buyers (Bids)

No. Vol. Price($)
5 1198 $9.75
 

Sellers (Offers)

Price($) Vol. No.
$9.90 192 1
View Market Depth
Last trade - 12.32pm 12/11/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.